Commercial-stage lung MRI medical device developer Polarean Imaging offered a fiscal results update for 2024.
Polarean expects to report unaudited revenue for the period (end-December 31) of between $3 million and $3.1 million, which will exceed its previous revenue guidance of $2.5 million to $3 million, it said.
It currently has 22 Xenon MRI platform customers. In 2024, sales of its Xenon gas blend cylinders and other consumables increased more than 50% compared with 2023.
Polarean’s unaudited cash and cash equivalents balance as of December 31, 2024, was $12.1 million, it noted.